Journal of Cystic Fibrosis
Volume 8, Issue 5 , Pages 356-359 , September 2009

What defines a pulmonary exacerbation? The perceptions of adults with cystic fibrosis

  • J. Abbott

      Affiliations

    • Faculty of Health, University of Central Lancashire, Preston, PR1 2HE, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 1772 893790.
    • ,
  • A. Holt

      Affiliations

    • Faculty of Health, University of Central Lancashire, Preston, PR1 2HE, UK
    • ,
  • A. Hart

      Affiliations

    • Faculty of Health, University of Central Lancashire, Preston, PR1 2HE, UK
    • ,
  • A.M. Morton

      Affiliations

    • Adult Cystic Fibrosis Unit, St James' Hospital, Leeds, LS9 7TF, UK
    • ,
  • L. MacDougall

      Affiliations

    • Adult Cystic Fibrosis Unit, Ninewells Hospital, Dundee, DD1 9SY, UK
    • ,
  • M. Pogson

      Affiliations

    • Adult Cystic Fibrosis Unit, Ninewells Hospital, Dundee, DD1 9SY, UK
    • ,
  • G. Milne

      Affiliations

    • Adult Cystic Fibrosis Unit, Ninewells Hospital, Dundee, DD1 9SY, UK
    • ,
  • H.C. Rodgers

      Affiliations

    • Adult Cystic Fibrosis Unit, Ninewells Hospital, Dundee, DD1 9SY, UK
    • ,
  • S.P. Conway

      Affiliations

    • Adult Cystic Fibrosis Unit, St James' Hospital, Leeds, LS9 7TF, UK

Received 2 April 2009 ,Revised 2 July 2009 ,Accepted 9 July 2009.

References 

  1. Britto MT, Kotagal UR, Hornung RW, Atherton HD, Tsevat J, Wilmott RW. Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest. 2002;121:64–72
  2. Goldbeck L, Zerrer S, Schmitz TG. Monitoring quality of life in outpatients with cystic fibrosis: feasibility and longitudinal results. J Cyst Fibros. 2007;6:171–178
  3. Smyth A, Elborn JS. Exacerbations in cystic fibrosis: 3 — Management. Thorax. 2008;63:180–184
  4. Liou TG, Adler FR, FitzSimmons SC, Cahill BC, Hibbs JR, Marshall BC. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol. 2001;153:345–352
  5. Ellaffi M, Vinsonneau C, Coste , Hubert D, Burgel PR, Dhainaut JF, et al. One year outcome after severe pulmonary exacerbation in adults with cystic fibrosis. AJRCCM. 2005;171:158–164
  6. Goss CH, Burns JL. Exacerbations in cystic fibrosis — 1: Epidemiology and pathogenesis. Thorax. 2007;62:360–367
  7. Ferkol T, Rosenfeld M, Milla CE. Cystic fibrosis pulmonary exacerbations. J Pediatr. 2006;148:259–264
  8. Dakin C, Henry R, Field P, Morton J. Defining an exacerbation of pulmonary disease in cystic fibrosis. Pediatr Pulmonol. 2001;31:436–442
  9. Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery AB, et al. Defining a pulmonary exacerbation in cystic fibrosis. Pediatr Pulmonol. 2001;139:359–365
  10. Rabin HR, Butler SM, Wohl ME, Geller DE, Colin AA, Schidlow DV, et al. Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol. 2004;37:400–406
  11. Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med. 1999;340:23–30
  12. Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med. 1994;331:637–642
  13. Wainwright S. Analysing data using grounded theory. Nurse Res. 1994;3:43–46
  14. Strauss A, Corbin J. Basics of Qualitative Research: Grounded Theory Procedures &Techniques. Newbury Park C.A.: Sage; 1990;
  15. Glaser B. Theoretical Sensitivity. Mill Valley, California: Advances Sociology Press; 1978;
  16. Abbott J, Hart A, Morton AM, Dey P, Conway SP, Webb AK. Can health-related quality of life predict survival in adults with cystic fibrosis?. Am J Respir Crit Care Med. 2009;179:54–58

PII: S1569-1993(09)00093-9

doi: 10.1016/j.jcf.2009.07.003

Journal of Cystic Fibrosis
Volume 8, Issue 5 , Pages 356-359 , September 2009

Article Tools